BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11277210)

  • 1. Aberrations of the p53 tumor suppressor gene in various tumors in dogs.
    Setoguchi A; Sakai T; Okuda M; Minehata K; Yazawa M; Ishizaka T; Watari T; Nishimura R; Sasaki N; Hasegawa A; Tsujimoto H
    Am J Vet Res; 2001 Mar; 62(3):433-9. PubMed ID: 11277210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of hyperamplification of centrosomes in naturally developing tumors of dogs.
    Setoguchi A; Okuda M; Nishida E; Yazawa M; Ishizaka T; Hong SH; Hisasue M; Nishimura R; Sasaki N; Yoshikawa Y; Masuda K; Ohno K; Tsujimoto H
    Am J Vet Res; 2001 Jul; 62(7):1134-41. PubMed ID: 11453492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P53 mutations in mammary tumor cell lines and corresponding tumor tissues in the dog.
    Van Leeuwen IS; Hellmèn E; Cornelisse CJ; Van den Burgh B; Rutteman GR
    Anticancer Res; 1996; 16(6B):3737-44. PubMed ID: 9042250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations of p53 tumor suppressor gene in spontaneous canine mammary tumors.
    Lee CH; Kweon OK
    J Vet Sci; 2002 Dec; 3(4):321-5. PubMed ID: 12819382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic alterations in eight mammary tumors and tumor-suppressor gene p53 mutation in one mammary tumor from dogs.
    Mayr B; Dressler A; Reifinger M; Feil C
    Am J Vet Res; 1998 Jan; 59(1):69-78. PubMed ID: 9442248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic organization of the canine p53 gene and its mutational status in canine mammary neoplasia.
    Chu LL; Rutteman GR; Kong JM; Ghahremani M; Schmeing M; Misdorp W; van Garderen E; Pelletier J
    Breast Cancer Res Treat; 1998 Jul; 50(1):11-25. PubMed ID: 9802616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of the p53 gene in human functional adrenal neoplasms.
    Lin SR; Lee YJ; Tsai JH
    J Clin Endocrinol Metab; 1994 Feb; 78(2):483-91. PubMed ID: 8106638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymerase chain reaction-based approaches for detection of allelic loss in the p53 tumor suppressor gene in colon neoplasms.
    Yamaguchi K; Sugano K; Fukayama N; Nakashima Y; Saotome K; Yokoyama T; Yokota T; Ohkura H
    Am J Gastroenterol; 1997 Feb; 92(2):307-12. PubMed ID: 9040212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P53 gene mutations in osteosarcomas in the dog.
    van Leeuwen IS; Cornelisse CJ; Misdorp W; Goedegebuure SA; Kirpensteijn J; Rutteman GR
    Cancer Lett; 1997 Jan; 111(1-2):173-8. PubMed ID: 9022143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products.
    Mashiyama S; Murakami Y; Yoshimoto T; Sekiya T; Hayashi K
    Oncogene; 1991 Aug; 6(8):1313-8. PubMed ID: 1886708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicancer-like syndrome in a dog characterized by p53 and cell cycle-checkpoint kinase 2 (CHK2) mutations and sirtuin gene (SIRT1) down-regulation.
    Marfe G; De Martino L; Tafani M; Irno-Consalvo M; Pasolini MP; Navas L; Papparella S; Gambacurta A; Paciello O
    Res Vet Sci; 2012 Aug; 93(1):240-5. PubMed ID: 21890154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 gene mutations occurring in spontaneous benign and malignant mammary tumors of the dog.
    Muto T; Wakui S; Takahashi H; Maekawa S; Masaoka T; Ushigome S; Furusato M
    Vet Pathol; 2000 May; 37(3):248-53. PubMed ID: 10810989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of p53 and retinoblastoma family pathways in canine osteosarcoma cell lines.
    Levine RA; Fleischli MA
    Vet Pathol; 2000 Jan; 37(1):54-61. PubMed ID: 10643981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrations of the p53 tumor suppressor gene in human epithelial ovarian carcinoma.
    Kim JW; Cho YH; Kwon DJ; Kim TE; Park TC; Lee JM; Namkoong SE
    Gynecol Oncol; 1995 May; 57(2):199-204. PubMed ID: 7729734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation of the p53 tumor suppressor gene in spontaneously occurring osteosarcomas of the dog.
    Johnson AS; Couto CG; Weghorst CM
    Carcinogenesis; 1998 Jan; 19(1):213-7. PubMed ID: 9472714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and significance of p53, rb, p21/waf-1, p16/ink-4a, and PTEN tumor suppressors in canine melanoma.
    Koenig A; Bianco SR; Fosmire S; Wojcieszyn J; Modiano JF
    Vet Pathol; 2002 Jul; 39(4):458-72. PubMed ID: 12126149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of tumour-associated and germ line p53 mutations in canine mammary cancer.
    Veldhoen N; Watterson J; Brash M; Milner J
    Br J Cancer; 1999 Oct; 81(3):409-15. PubMed ID: 10507764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel canine tumour suppressor gene p53 mutations in cases of skin and mammary neoplasms.
    Mayr B; Reifinger M; Alton K
    Vet Res Commun; 1999 Aug; 23(5):285-91. PubMed ID: 10493115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
    Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T
    Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of p53 mutation using PCR-SSCP silver staining method].
    Zhao W; Si J; Li K; Zhang X; Song G
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Jun; 17(3):219-22. PubMed ID: 8706159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.